BROOKFIELD, NEWS, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the quarter ended September 30, 2024. Sachin Shah, CEO...
Bentley Pharmaceuticals, Inc. (NYSE: BNT) (?Bentley? or the ?Company?) announced today that its stockholders have approved the Agreement and Plan of Merger, dated as of March...
Bentley Pharmaceuticals, Inc. (NYSE: BNT) (?Bentley? or the ?Company?) announced today that it notified the New York Stock Exchange (the ?NYSE?) of its intent to delist its...
The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business into a new publicly traded company to be called...
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the first quarter and three months ended March 31, 2008...
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss first-quarter 2008...
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which...
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2007...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.43 | -5.76955424727 | 59.45 | 59.45 | 55.28 | 11811 | 57.04936908 | CS |
4 | -1.74 | -3.01246537396 | 57.76 | 62.26 | 55.28 | 13640 | 59.56746017 | CS |
12 | 2.23 | 4.14575199851 | 53.79 | 62.26 | 52.12 | 11815 | 56.64277674 | CS |
26 | 8.76 | 18.5357596276 | 47.26 | 62.26 | 46.1 | 12283 | 55.45076483 | CS |
52 | 8.76 | 18.5357596276 | 47.26 | 62.26 | 46.1 | 12283 | 55.45076483 | CS |
156 | 8.76 | 18.5357596276 | 47.26 | 62.26 | 46.1 | 12283 | 55.45076483 | CS |
260 | 8.76 | 18.5357596276 | 47.26 | 62.26 | 46.1 | 12283 | 55.45076483 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約